Next Generation News and Research

RSS

Research gives scientists new insight into evolution of gibbon genome

A team led by an Oregon Health & Science University researcher has sequenced and annotated the genome of the only ape whose DNA had yet to be sequenced - the gibbon, an endangered small ape that inhabits the tropical forests of Southeast Asia.

11 Sep 2014

Picwell’s first recommendation engine uses predictive analytics to rate health plan options

Picwell, the first recommendation engine to use predictive analytics to rate consumer health plan options according to individual needs, today announced its official launch.

10 Sep 2014

Codman Neuro Receives Approval for REVIVE SE Thrombectomy Device in China, South Korea and Taiwan

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, announced regulatory approval from the China Food and Drug Administration, South Korea’s Ministry of Food and Drug Safety, and the Taiwan Food and Drug Administration for the company’s REVIVE SE Thrombectomy Device, a next-generation self-expanding clot removal device intended to restore blood flow in patients with acute ischemic stroke secondary to intracranial occlusive vessel disease.

4 Sep 2014

Two fully automated molecular testing systems for blood and plasma donor screening launched by Roche

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the commercial availability of the cobas 6800/8800 Systems, two integrated and fully automated molecular testing systems for blood and plasma donor screening, in markets accepting the CE mark. The cobas 6800/8800 Systems offer the fastest time to results with the highest throughput available, along with the longest walk-away time, enabling laboratory staff to drive increased workflow efficiencies, while adapting to their ever-changing testing demands.

From Roche Sequencing and Life Science 2 Sep 2014

Extracting Cardiac Leads: An Interview with Barry Norlander from Cook Medical

The pacemaker or ICD unit, which is the implanted box or generator i.e. the electrical component of the device that's implanted in the chest, usually lasts between seven to 10 years before the generator’s battery is depleted.

From COOK MEDICAL INC. 2 Sep 2014

Wockhardt receives coveted QIDP status from FDA for WCK 771 and WCK 2349 drugs

Wockhardt Limited today announces a major boost to the New Drug Discovery program in Anti-Infective research when two of its drugs, WCK 771 and WCK 2349, received the coveted Qualified Infectious Disease Product (QIDP) status from U.S. Food & Drug Administration.

1 Sep 2014

Valurise Health Solutions honored as 2014 Red Herring Top 100 Asia Winner

Valurise Health Solutions was awarded as the 2014 Red Herring Top 100 Asia Winner, being the only award-winning healthcare service company, standing out from creative leading companies in Asia for its re-defining industry with innovative business model and continuous innovation ability.

29 Aug 2014

Wake Forest Baptist Medical Center receives NCORP grant to conduct cancer clinical trials

Wake Forest Baptist Medical Center has received an $18 million, five-year grant from the National Cancer Institute's Community Oncology Research Program to design and conduct community-based, multi-center screening, prevention and control cancer clinical trials.

29 Aug 2014

Cilag GmbH International acquires biopharmaceutical company, Covagen AG

Cilag GmbH International, an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has acquired Covagen AG, a privately-held, biopharmaceutical company specializing in the development of multispecific protein therapeutics through the FynomAb® technology platform.

25 Aug 2014

Penn Medicine launches CAROT to build novel therapies for retinal and ocular disorders

The Perelman School of Medicine at the University of Pennsylvania has launched the Penn Center for Advanced Retinal and Ocular Therapeutics (CAROT) to build on its previous success developing novel therapies for the personalized diagnosis and treatment of retinal and ocular disorders.

22 Aug 2014

DNA testing for congenital cataracts can accurately diagnose diseases linked to childhood blindness

Researchers in the United Kingdom have demonstrated that advanced DNA testing for congenital cataracts can quickly and accurately diagnose a number of rare diseases marked by childhood blindness, according to a study published online today in Ophthalmology, the journal of the American Academy of Ophthalmology.

22 Aug 2014

IMRIS receives licensing to incorporate MRI core technology into VISIUS Surgical Theatre in Canada

IMRIS Inc. today announced that the Company has received Health Canada licensing to incorporate next generation MRI core technology into the VISIUS Surgical Theatre for sales and marketing in the country.

22 Aug 2014

Deep sequencing technique opens up new possibilities for finding genetic causes for brain disorder

Not every cell in the body is the same genetically, and disease-causing mutations don't necessarily affect every cell—making these mutations easy to miss even with next-generation genomic sequencing.

21 Aug 2014

Using a nanotech microchip to diagnose type 1 diabetes: an interview with Dr. Brian Feldman, Stanford School of Medicine

The most common form of diabetes is sometimes referred to as metabolic diabetes, which is the diabetes most people are very familiar with, type 2 diabetes. This form of diabetes is most prevalent in people that are overweight or obese. Historically, it has been confined to adults or older patients but it has been on the rise as the global obesity problem has continued to worsen.

20 Aug 2014

Actavis reports positive results from ceftazidime-avibactam Phase III studies in cIAI patients

Actavis plc today confirmed positive topline results from RECLAIM-1 and -2, pivotal Phase III studies evaluating the potential for the investigational antibiotic, ceftazidime-avibactam as a treatment for adult hospitalized patients with complicated intra-abdominal infections.

19 Aug 2014

BGRF scientists propose Oncofinder method for accurate analysis of gene expression data

Scientists from the Biogerontology Research Foundation (BGRF), a UK-based charity founded to support ageing research and address the challenges of a rapidly ageing population, propose a new concept for signalome-wide analysis of changes in intracellular pathways, called OncoFinder, which allows for accurate and robust cross-platform analysis of gene expression data.

19 Aug 2014

Next Generation News and Research

Research gives scientists new insight into evolution of gibbon genome

Picwell’s first recommendation engine uses predictive analytics to rate health plan options

Codman Neuro Receives Approval for REVIVE SE Thrombectomy Device in China, South Korea and Taiwan

Two fully automated molecular testing systems for blood and plasma donor screening launched by Roche

Extracting Cardiac Leads: An Interview with Barry Norlander from Cook Medical

Wockhardt receives coveted QIDP status from FDA for WCK 771 and WCK 2349 drugs

Valurise Health Solutions honored as 2014 Red Herring Top 100 Asia Winner

Wake Forest Baptist Medical Center receives NCORP grant to conduct cancer clinical trials

Cilag GmbH International acquires biopharmaceutical company, Covagen AG

Penn Medicine launches CAROT to build novel therapies for retinal and ocular disorders

DNA testing for congenital cataracts can accurately diagnose diseases linked to childhood blindness

IMRIS receives licensing to incorporate MRI core technology into VISIUS Surgical Theatre in Canada

Deep sequencing technique opens up new possibilities for finding genetic causes for brain disorder

Using a nanotech microchip to diagnose type 1 diabetes: an interview with Dr. Brian Feldman, Stanford School of Medicine

Actavis reports positive results from ceftazidime-avibactam Phase III studies in cIAI patients

BGRF scientists propose Oncofinder method for accurate analysis of gene expression data

NIH challenges innovators to compete for prizes by developing new ways to track a single cell

HCN to acquire HealthLease REIT and 17 of Mainstreet's Next Generation properties

Discovery of new mechanism could lead to next generation of drugs to treat schizophrenia

TAXIS acquires novel antimicrobial drug candidates from Biota

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News